The European Antibody Congress is where pharma, biotechs, clinicians, researchers & innovative start-ups gather to develop new strategies and partnerships to advance antibody drug discovery, development, and commercialisation.Join the largest antibody event focused on getting important new therapeutics and immunotherapies into the clinic and see where antibody development is headed next.2015 key speakers include:• Dr Peter Senter, Vice President of Chemistry, Seattle Genetics• Dr Emma Lees, Vice President, Oncology Biotherapeutics, Novartis Institute for Biomedical Research (NIBR)• Dr Hans-Peter Gerber, Vice President, Pfizer Worldwide Research & Development, Pfizer• Dr Michael Postow, Medical Oncology Fellow Medicine, Memorial Sloan Kettering• Dr Christian Klein, Head of Oncology Programs, Roche